Shine Investment Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$68K Sell
238
-17
-7% -$4.74K 0.02% 245
2020
Q2
$68K Sell
255
-6
-2% -$1.8K 0.02% 245
2020
Q1
$83K Buy
261
+23
+10% +$6.98K 0.04% 203
2019
Q4
$71K Sell
238
-56
-19% -$15.5K 0.03% 259
2019
Q3
$68K Hold
294
0.03% 247
2019
Q2
$69K Hold
294
0.03% 248
2019
Q1
$69K Buy
294
+199
+209% +$62.7K 0.03% 241
2018
Q4
$29K Hold
95
0.01% 376
2018
Q3
$34K Hold
95
0.02% 370
2018
Q2
$28K Hold
95
0.01% 397
2018
Q1
$26K Sell
95
-87
-48% -$27K 0.01% 419
2017
Q4
$58K Buy
182
+5
+3% +$1.6K 0.03% 266
2017
Q3
$55K Sell
177
-6
-3% -$1.78K 0.03% 278
2017
Q2
$50K Buy
+183
New +$48.4K 0.03% 278

Other funds holding BIIB

Shine Investment Advisory Services's BIIB Position: Q3 2020 in Review

Shine Investment Advisory Services reduced its Biogen (BIIB) stake by 6.7% in Q3 2020, selling an estimated $4.74K and leaving 238 shares worth $68K. The position accounts for 0.02% of the portfolio, ranked #245.

Shine Investment Advisory Services first reported a position in BIIB in Q2 2017 and has held it in 14 quarters since. The position peaked at $83K in Q1 2020. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Shine Investment Advisory Services held 238 shares of Biogen worth $68K as of Q3 2020.
  • Shine Investment Advisory Services sold 17 Biogen shares in Q3 2020, an estimated $4.74K.
  • Biogen made up 0.02% of Shine Investment Advisory Services's portfolio in Q3 2020, its #245 holding.
  • Shine Investment Advisory Services first reported a position in Biogen in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Biogen position peaked at $83K in Q1 2020.
  • 1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.